rs10779279

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000359162.6(ESRRG):​c.-13-75139C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0694 in 152,088 control chromosomes in the GnomAD database, including 450 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.069 ( 450 hom., cov: 32)

Consequence

ESRRG
ENST00000359162.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.303

Publications

7 publications found
Variant links:
Genes affected
ESRRG (HGNC:3474): (estrogen related receptor gamma) This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000359162.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESRRG
NM_001134285.3
c.-13-75139C>T
intron
N/ANP_001127757.1
ESRRG
NM_001243509.2
c.-13-75139C>T
intron
N/ANP_001230438.1
ESRRG
NM_001243510.3
c.-13-75139C>T
intron
N/ANP_001230439.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ESRRG
ENST00000359162.6
TSL:1
c.-13-75139C>T
intron
N/AENSP00000352077.2
ESRRG
ENST00000360012.7
TSL:1
c.-14+52313C>T
intron
N/AENSP00000353108.3
ESRRG
ENST00000361395.6
TSL:1
c.-13-75139C>T
intron
N/AENSP00000354584.2

Frequencies

GnomAD3 genomes
AF:
0.0695
AC:
10567
AN:
151970
Hom.:
450
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0167
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0868
Gnomad ASJ
AF:
0.0866
Gnomad EAS
AF:
0.0225
Gnomad SAS
AF:
0.111
Gnomad FIN
AF:
0.134
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.0875
Gnomad OTH
AF:
0.0789
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0694
AC:
10562
AN:
152088
Hom.:
450
Cov.:
32
AF XY:
0.0718
AC XY:
5338
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.0167
AC:
693
AN:
41538
American (AMR)
AF:
0.0866
AC:
1321
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0866
AC:
300
AN:
3466
East Asian (EAS)
AF:
0.0221
AC:
114
AN:
5152
South Asian (SAS)
AF:
0.111
AC:
536
AN:
4816
European-Finnish (FIN)
AF:
0.134
AC:
1423
AN:
10582
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0875
AC:
5944
AN:
67954
Other (OTH)
AF:
0.0795
AC:
168
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
501
1002
1503
2004
2505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0824
Hom.:
1741
Bravo
AF:
0.0628
Asia WGS
AF:
0.0560
AC:
193
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.1
DANN
Benign
0.63
PhyloP100
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10779279; hg19: chr1-216925972; API